Search for: "Medtronic Minimed, Inc." Results 1 - 20 of 64
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Feb 2019, 2:44 pm by admin
INTRODUCTION On September 28, 2004, the United States Supreme Court granted a property owner’s application for leave from a Connecticut Supreme Court decision upholding the constitutionality of the community’s taking of property with the specified purpose of creating jobs by selling the property to a private industrial user.1 As the petitioner land owners in Kelo express in their brief requesting leave, the critical question for the Court to determine is whether a taking for purely… [read post]
15 Sep 2018, 2:00 pm by Corbin Bridge
Major Companies [1] Medtronic PLC Medtronic develops and manufactures medical devices for chronic diseases and commands 40.2% of the market share. [read post]
17 Feb 2016, 4:30 am
Medtronic, Inc., 552 U.S. 312 (2008), where he held that most tort claims against PMA devices are expressly preempted by a federal statute. [read post]
4 Jan 2016, 5:51 pm by Ben Vernia
Kyphoplasty is a minimally-invasive procedure used to treat certain spinal fractures that often are due to osteoporosis. [read post]
6 Feb 2015, 1:00 pm by Greene LLP
Medtronic, Inc. was filed in federal court in New York by Jason Nickell, a former Medtronic sales representative. [read post]
15 Jan 2015, 12:17 pm by Lawrence B. Ebert
Medtronic Sofamor Danek, Inc., 567 F.3d1314, 1336 (Fed. [read post]
2 Sep 2014, 4:27 am by Kevin LaCroix
” He added the warning that “boards that choose to ignore, or minimize the importance of cybersecurity oversight responsibility, do so at their own peril. [read post]
2 Jun 2014, 5:07 am
LifePort has also asserted another patent against Gore that overlaps with the defendants Medtronic, Inc. and Medtronic Vascular, Inc. [read post]
2 Jul 2013, 8:11 am by Ben Vernia
Kyphoplasty is a minimally-invasive procedure used to treat certain spinal fractures that often are due to osteoporosis. [read post]
6 Nov 2012, 9:08 am
According to a report by Senate investigators, Medtronic Inc., the world largest medical device maker, wrote and edited medical journal articles attributed to outside physicians, which minimized the risks of the company's Infuse BMP-2 bone graft. [read post]